Journal of Clinical Trials : Citations & Metrics Report
Articles published in Journal of Clinical Trials have been cited by esteemed scholars and scientists all around the world. Journal of Clinical Trials has got h-index 22, which means every article in Journal of Clinical Trials has got 22 average citations.
Following are the list of articles that have cited the articles published in Journal of Clinical Trials.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total published articles |
64 | 66 | 79 | 78 | 38 | 20 | 35 | 52 | 44 | 54 | 25 | 31 | 3 |
Research, Review articles and Editorials |
27 | 33 | 67 | 44 | 22 | 11 | 20 | 39 | 41 | 47 | 19 | 27 | 3 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
37 | 33 | 12 | 34 | 16 | 9 | 15 | 13 | 3 | 7 | 6 | 4 | 0 |
Conference proceedings |
0 | 5 | 12 | 0 | 15 | 115 | 118 | 56 | 63 | 0 | 0 | 0 | 0 |
Citations received as per Google Scholar, other indexing platforms and portals |
175 | 190 | 167 | 179 | 137 | 137 | 143 | 0 | 0 | 0 | 0 | 0 | 0 |
| Journal total citations count | 1734 |
| Journal impact factor | 2.76 |
| Journal 5 years impact factor | 3.07 |
| Journal cite score | 3.14 |
| Journal h-index | 22 |
| Journal h-index since 2019 | 16 |
Important citations (609)
immuno-oncology: commiserating the function and abortive of the immune system in cancer: a review |
|
The development of treatment of gastric cancer with liver metastasis |
|
Effects of thermal ablation on treg/th17 in hepatocellular carcinoma of mice |
|
Advanced hepatocellular carcinoma treated by radiofrequency ablation combined with oncolytic virus and anti-pd-1 antibody therapy: a case report and literature review |
|
Evaluation of microwave ablation efficacy by strain elastography and shear wave elastography in ex vivo porcine liver. |
|
immunological markers, prognostic factors and challenges following curative treatments for hepatocellular carcinoma |
|
Immunological markers, prognostic factors and challenges following curative treatments for hepatocellular carcinoma |
|
Sunitinib and sorafenib modulating antitumor immunity in hepatocellular cancer |
|
Long-term survival of a patient with advanced pancreatic cancer under adjunct treatment with viscum album extracts: a case report |
|
development of incvax, in situ cancer vaccine, and its immune response in mice with hepatocellular cancer |
|
Hepatic thermal injury promotes colorectal cancer engraftment in c57/black 6 mice |
|
Hepatic thermal injury promotes colorectal cancer engraftment in c57/black 6 mice |
|
Microwave or radiofrequency ablation: clinically equivalent |
|
image-guided locoregional non-intravascular interventional treatments for hepatocellular carcinoma: current status |
|
Immuno-oncology and its opportunities for interventional radiologists: immune checkpoint inhibition and potential synergies with interventional oncology procedures |
|
Imbrave 050: a phase iii trial of atezolizumab plus bevacizumab in high-risk hepatocellular carcinoma after curative resection or ablation |
|
Hyperthermia ablation combined with transarterial chemoembolization versus monotherapy for hepatocellular carcinoma: a systematic review and meta-analysis. |
|
Developing a roadmap for interventional oncology |
|
Non-thermal histotripsy tumor ablation promotes abscopal immune responses that enhance cancer immunotherapy |
|
Breast cancer and use of alternative medicine: a mini review |
|